Document:

EX-10.1

 Exhibit 10.1 
 MEI PHARMA, INC. 
 AMENDED AND RESTATED 

2008 STOCK OMNIBUS EQUITY COMPENSATION PLAN 
 Section 1. Purpose 
 The Plan authorizes the Compensation Committee to
provide Advisors, Employees and Non-Employee Directors that are providing, or have agreed to provide, services to the Company or its Affiliates, who are in a position to contribute to the long-term success of the Company or its Affiliates, with
Grants. The Company believes that this incentive program will cause those Advisors, Employees and Non-Employee Directors to increase their interest in the welfare of the Company and its Affiliates, and aid in attracting, retaining and motivating
Advisors, Employees and Non-Employee Directors of outstanding ability. 
 The Plan was originally effective as of
December 9, 2008 upon approval by the stockholders of the Company, and amended and restated effective October 21, 2011, provided, however, that the share increase was effective December 1, 2011 upon approval by the stockholders
of the Company. This amendment and restatement is effective as of January 29, 2013; provided that the share increases contemplated under Section 3 will be effective March 26, 2013, subject to approval by the stockholders of the
Company 
 Section 2. Definitions 
 Capitalized terms used herein shall have the meanings set forth in this Section. 

(a) “Advisor” shall mean advisors who render bona fide services to the Company or its subsidiaries where the services are not
in connection with the offer and sale of securities in a capital-raising transaction and the Advisors do not directly or indirectly promote or maintain a market for the Company’s securities. 

(b) “Affiliate” shall mean any Person which is included as a member with the Company in a controlled group of corporations,
within the meaning of Code section 414(b), or which is a trade or business (whether or not incorporated) included with the Company in a group of trades or business under common control, within the meaning of Code section 414(c); provided,
however, that in applying Code sections 1563(a)(1), (2) and (3) for purposes of determining a controlled group of corporations under Code section 414(b), the language “at least 20 percent” is used instead of “at least
80 percent” each place it appears in Code sections 1563(a)(1), (2) and (3), and in applying Treas. Reg. section 1.414(c)-2 for purposes of determining trades or businesses (whether or not incorporated) that are under common control for
purposes of Code section 414(c), the language “at least 20 percent” is used instead of “at least 80 percent” each place it appears in Treas. Reg. section 1.414(c)-2. 

(c) “Board” shall mean the Board of Directors of the Company. 

(d) “Cause” shall have the meaning ascribed thereto in any effective employment or

  
 1 

 
service agreement between the Company and the Grantee, or if no employment agreement is in effect that contains a definition of cause, then Cause shall mean a finding by the Compensation
Committee, in its sole and absolute discretion, that the Grantee has (i) committed a felony or a crime involving moral turpitude, (ii) committed any act of gross negligence or fraud, (iii) failed, refused or neglected to substantially
perform his duties (other than by reason of a physical or mental impairment) or to implement the directives of the Company, (iv) materially violated any policy of the Company, or (v) engaged in conduct that is materially injurious to the
Company, monetarily or otherwise. 
 (e) “Change in Control” shall be deemed to have occurred if: 

(i) Any “person” (as such term is used in sections 13(d) and 14(d) of the Exchange Act) becomes a “beneficial owner”
(as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing more than 50% of the voting power of the then outstanding securities of the Company; provided that a Change in Control shall not be
deemed to occur as a result of a transaction in which the Company becomes a subsidiary of another corporation and in which the stockholders of the Company, immediately prior to the transaction, will beneficially own, immediately after the
transaction, shares entitling such stockholders to more than 50% of all votes to which all stockholders of the parent corporation would be entitled in the election of directors. 

(ii) The consummation of (A) a merger or consolidation of the Company with another corporation where the stockholders of the
Company, immediately prior to the merger or consolidation, will not beneficially own, immediately after the merger or consolidation, shares entitling such stockholders to more than 50% of all votes to which all stockholders of the surviving
corporation would be entitled in the election of directors, or where the members of the Board, immediately prior to the merger or consolidation, would not, immediately after the merger or consolidation, constitute a majority of the board of
directors of the surviving corporation, (B) a sale or other disposition of all or substantially all of the assets of the Company, or (C) a liquidation or dissolution of the Company. 
 Notwithstanding the foregoing definition of Change in Control, the Compensation Committee may modify the definition of Change in Control for a particular Grant as it deems appropriate to comply with Code
section 409A or otherwise. 
 (f) “Code” shall mean the Internal Revenue Code of 1986, as amended and the regulations
promulgated thereunder. 
 (g) “Company” shall mean MEI Pharma, Inc., a corporation organized under the laws of the
State of Delaware. 
 (h) “Compensation Committee” shall mean the members of the Board appointed by the Board to serve
as the Compensation Committee with responsibility for the administration of the Plan, or if no such members of the Board are appointed, then the Compensation Committee shall consist of all of the members of the Board. In any case, the Board shall
approve and administer all grants made to Non-Employee Directors. The members of the Board appointed to 

  
 2 

 
serve as the Compensation Committee, if applicable, should consist of two or more Persons who are “outside directors” as defined under Code section 162(m), and related Treasury
regulations, and “non-employee directors” as defined under Rule 16b-3 under the Exchange Act. To the extent that the Board or a subcommittee administers the Plan, references in the Plan to the “Compensation Committee” shall be
deemed to refer to the Board or such subcommittee. 
 (i) “Disability” or “Disabled” shall mean a
Grantee’s becoming disabled within the meaning of Code section 22(e)(3) or as otherwise determined by the Compensation Committee. 
 (j) “Employee” shall mean any individual that is providing, or has agreed to provide, services to the Company or an Affiliate of the Company as an employee. 

(k) “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended. 

(l) “Exercise Price” shall mean the purchase price of a Share subject to an Option, which shall not be less than the Fair
Market Value of a Share as of the date an Option is granted. 
 (m) “Fair Market Value” of a Share on any given date,
unless the Compensation Committee determines otherwise with respect to a particular Grant, shall mean (i) if the principal trading market for the Shares is a national securities exchange, the last reported sale price during regular trading
hours thereof of a Share on the relevant date or (if there were no trades on that date) the last reported sales price during regular trading hours on the latest preceding date upon which a sale was reported, (ii) if the Shares are not
principally traded on such exchange, the mean between the last reported “bid” and “asked” prices of a Share during regular trading hours on the relevant date, as reported on the OTC Bulletin Board, or (iii) if the Shares are
not publicly traded or, if publicly traded, are not so reported, the Fair Market Value per share shall be as determined by the Compensation Committee pursuant to any reasonable valuation method authorized under the Code. 

(n) “Grant” shall mean a grant of Options, SARs, Stock Awards, Stock Units or Other Stock-Based Awards under the Plan.

 (o) “Grant Letter” shall mean a letter, certificate or other agreement accepted by the Grantee, evidencing the
making of a Grant hereunder and containing such terms and conditions, not inconsistent with the express provisions of the Plan, as the Compensation Committee shall approve. 
 (p) “Grantee” shall mean an Advisor, Employee or Non-Employee Director made a Grant under the Plan. 
 (q) “ISO” shall mean any Option or portion thereof that meets the requirements of an incentive stock option under Code section 422 and that is designated by the Compensation Committee to be an
ISO. 
 (r) “Non-Employee Director” shall mean a member of the Board who is not an Employee. 

  
 3 

 (s) “Nonqualified Option” shall mean any Option or portion thereof that is not an
ISO. 
 (t) “Options” shall refer to options issued under and subject to the Plan. 

(u) “Other Stock-Based Award” shall mean any Grant based on, measured by or payable in Shares, as described in Section 9.

 (v) “Person” shall mean an individual, partnership, corporation, limited liability company or partnership, trust,
unincorporated organization, joint venture, government (or agency or political subdivision thereof) or any other entity of any kind. 
 (w) “Plan” shall mean this Amended and Restated MEI Pharma, Inc. 2008 Omnibus Equity Compensation Plan as set forth herein and as amended from time to time. 

(x) “SAR” shall mean a stock appreciation right with respect to a Share. 

(y) “Share” shall mean a share of common stock of the Company. 

(z) “Stock Award” shall mean an award of Shares, with or without restrictions. 

(aa) “Stock Unit” shall mean a unit that represents a hypothetical Share. 

Section 3. Shares Available under the Plan 
 (a) Shares Authorized. Subject to the provisions of Section 13, the aggregate number of Shares that may be issued or transferred under the Plan shall be equal to the sum of the following:
(i) 1,769,344 Shares, plus (ii) the number of Shares subject to outstanding Grants under the Plan as of March 26, 2013, plus (iii) the number of Shares remaining available for issuance under the Plan but not subject to previously
exercised, vested or paid Grants as of March 26, 2013; provided that in no event shall the maximum aggregate numbers of Shares that may be issued or transferred under the Plan exceed 2,186,000. If and to the extent Options or SARs granted under
the Plan terminate, expire or are canceled, forfeited, exchanged or surrendered without having been exercised or if any Stock Awards, Stock Units or Other Stock-Based Awards are forfeited, terminated or otherwise not paid in full, the Shares subject
to such Grants may again be available for purposes of the Plan. Shares surrendered in payment of the Exercise Price of an Option, and Shares withheld or surrendered for payment of taxes, shall not be available for re-issuance under the Plan. Upon
the exercise of an Option through the net exercise procedure under Section 5(d) or upon the exercise of a SAR, then both for purposes of calculating the number of Shares remaining available for issuance under the Plan and the number of Shares
remaining available for exercise under such Option or SAR, the number of such Shares shall be reduced by the gross number of Shares for which the Option or SAR is exercised and without regard to any cash settlement of a SAR. Except as provided with
respect to cash settlement of SARs, to the extent that any Grants are paid in cash and not in Shares, any Shares previously subject to such Grants shall again be available for issuance or transfer under the Plan and shall not count against the share
limits in this Section 3(a). 

  
 4 

 (b) Individual Limits. The maximum aggregate number of Shares that shall be subject
to Grants made under the Plan to any individual during any calendar year shall be 400,000 Shares, subject to adjustment as described in Section 13 below. Shares that shall be subject to Options or SARS made under the Plan to any individual
during any calendar year shall not exceed such number of Shares set forth above in this Section 3(b). 
 Section 4. Administration of
the Plan 
 (a) Authority of the Compensation Committee. The Plan shall be administered by the Compensation Committee.
The Compensation Committee shall have full and final authority to take the following actions, in each case subject to and consistent with the provisions of the Plan: 

(i) to select the Advisors, Employees and Non-Employee Directors to whom Grants may be made; 

(ii) to determine the number of Shares subject to each such Grant; 

(iii) to determine the terms and conditions of any Grant made under the Plan; 

(iv) to determine whether to accelerate the exercisability of any or all applicable outstanding Grants at any time for any
reason; 
 (v) to determine the restrictions or conditions related to the delivery, holding and disposition of
Shares acquired pursuant to a Grant; 
 (vi) to prescribe the form of each Grant Letter; 

(vii) to adopt, amend, suspend, waive and rescind such rules and regulations and appoint such agents as the Compensation
Committee may deem necessary or advisable to administer the Plan; 
 (viii) to correct any defect or supply any
omission or reconcile any inconsistency in the Plan and to construe and interpret the Plan and any Grant, Grant Letter or other instrument hereunder; and 
 (ix) to make all other decisions and determinations as may be required under the terms of the Plan or as the Compensation Committee may deem necessary or advisable for the administration of the Plan.

 All Grants shall be made conditional upon the Grantee’s acknowledgement, in writing or by acceptance of the Grant, that
all decisions and determinations of the Compensation Committee shall be final and binding on the Grantee, his or her beneficiaries and any other Person having or claiming an interest under such Grant. 

(b) Manner of Exercise of Compensation Committee Authority. Any action of the Compensation Committee with respect to the Plan
shall be final, conclusive and binding on all 

  
 5 

 
Persons, including the Company, its Affiliates, Grantees, or any Person claiming any rights under the Plan from or through any Grantee, except to the extent the Compensation Committee may
subsequently modify, or take further action not inconsistent with, its prior action. If not specified in the Plan, the time at which the Compensation Committee must or may make any determination shall be determined by the Compensation Committee, and
any such determination may thereafter be modified by the Compensation Committee. The express grant of any specific power to the Compensation Committee, and the taking of any action by the Compensation Committee, shall not be construed as limiting
any power or authority of the Compensation Committee. The Compensation Committee may delegate to officers or managers of the Company or any Affiliate of the Company the authority, subject to such terms as the Compensation Committee shall determine,
to perform such functions as the Compensation Committee may determine, to the extent permitted under applicable law. 
 (c)
Limitation of Liability. Each member of the Compensation Committee shall be entitled to, in good faith, rely or act upon any report or other information furnished to him by any officer or other employee of the Company or any of its
Affiliates, the Company’s independent certified public accountants or any executive compensation consultant, legal counsel or other professional retained by the Company to assist in the administration of the Plan. To the fullest extent
permitted by applicable law, no member of the Compensation Committee, nor any officer or employee of the Company acting on behalf of the Compensation Committee, shall be personally liable for any action, determination or interpretation taken or made
in good faith with respect to the Plan, and all members of the Compensation Committee and any officer or employee of the Company acting on its behalf shall, to the extent permitted by law, be fully indemnified and protected by the Company with
respect to any such action, determination or interpretation. 
 Section 5. Options 

The Compensation Committee may grant Options to an Employee, Advisor or member of the Board upon such terms as the Compensation Committee
deems appropriate. The following provisions are applicable to Options: 
 (a) Number of Shares. The Compensation
Committee shall determine the number of Shares that will be subject to each Grant of Options to an Employee, Advisor or member of the Board. 
 (b) Type of Option and Price. 
 (i) The Compensation Committee may grant
ISOs or Nonqualified Stock Options or any combination of the two, all in accordance with the terms and conditions set forth herein. ISOs may be granted only to employees of the Company or its parent or subsidiary corporations, as defined in Code
section 424. Nonqualified Options may be granted to Employees, Advisors or members of the Board. 
 (ii) The Exercise Price of
Shares subject to an Option shall be determined by the Compensation Committee and may be equal to or greater than the Fair Market Value of a 

  
 6 

 
Share on the date the Option is granted. However, an ISO may not be granted to an Employee who, at the time of grant, owns stock possessing more than 10% of the total combined voting power of all
classes of stock of the Company, or any parent or subsidiary corporation of the Company, as defined in Code section 424, unless the Exercise Price per Share is not less than 110% of the Fair Market Value of a Share on the date of grant. 

(iii) Each ISO shall provide that, if the aggregate Fair Market Value of the Shares on the date of the grant with respect to which ISOs
are exercisable for the first time by a Grantee during any calendar year, under the Plan or any other stock option plan of the Company or a parent or subsidiary of the Company, exceeds $100,000, then the Option, as to the excess, shall be treated as
a Nonqualified Option. 
 (c) Option Term. The Compensation Committee shall determine the term of each Option. The term
of any Option for shall not exceed five years from the date of grant. 
 (d) Option Termination. Except as provided
below, an Option may only be exercised while the Grantee is employed or engaged by the Company or any Affiliate as an Advisor, Employee or member of the Board. Unless otherwise determined by the Compensation Committee and set forth in a Grant
Letter, Options shall terminate on the earliest of: 
 (i) the date on which the Grantee is no longer employed or engaged by the
Company and any Affiliate on account of the Grantee’s termination for Cause. In addition, notwithstanding any other provisions of this Section 5, if the Compensation Committee determines that the Grantee has engaged in conduct that
constitutes Cause at any time while the Grantee is employed or engaged by the Company and any Affiliate or after the Grantee’s termination of employment or engagement, any Option held by the Grantee shall immediately terminate and the Grantee
shall automatically forfeit all Shares underlying any exercised portion of an Option for which the Company has not yet delivered the Share certificates, upon refund by the Company of the Exercise Price paid by the Grantee for such Shares. Upon any
exercise of an Option, the Company may withhold delivery of Share certificates pending resolution of an inquiry that could lead to a finding resulting in a forfeiture; 
 (ii) the 91st day following the date the Grantee is no longer employed or engaged by the Company and any Affiliate for any reason other than Cause, death, or Disability; provided, however,
that in all cases the portion of any Option that is not vested on the date of termination of employment or engagement shall terminate immediately upon such termination; 
 (iii) the first anniversary of the date the Grantee’s employment or engagement by the Company and any Affiliate terminates on account of the Grantee’s death or Disability; provided,
however, that the portion of any Option that is not vested on the date of such termination of employment or engagement shall terminate immediately upon such termination; 

(iv) the fifth anniversary of the date of grant as set forth in the Grant Letter; and 

(v) cancellation, termination or expiration of the Options pursuant to action taken by the Compensation Committee in accordance with
Section 13. 

  
 7 

 For purposes of the Plan, employment or engagement by the Company and any Affiliate shall
mean employment or service as an Employee, Advisor or member of the Board (so that, for purposes of exercising Options, a Grantee shall not be considered to have terminated his employment or engagement until the Grantee ceases to be an Employee,
Advisor and member of the Board), unless the Compensation Committee determines otherwise. 
 (e) Exercise of Options.
Only the vested portion of any Option may be exercised. A Grantee may exercise an Option that has become exercisable, in whole or in part, by delivering a notice of exercise to the Company. The Grantee shall pay the Exercise Price for an Option as
specified by the Compensation Committee (i) in cash, (ii) unless the Compensation Committee determines otherwise, by delivering Shares owned by the Grantee and having a Fair Market Value on the date of exercise at least equal to the
Exercise Price or by attestation (on a form prescribed by the Compensation Committee) to ownership of Shares having a Fair Market Value on the date of exercise at least equal to the Exercise Price, (iii) by payment through a broker in
accordance with procedures permitted by Regulation T of the Federal Reserve Board, or (iv) by such other method as the Compensation Committee may approve. In addition, in the event the Compensation Committee so determines, to the extent an
Option is at the time exercisable for vested shares of Company Stock, all or any part of that vested portion may be surrendered to the Company for an appreciation distribution payable in Shares with a Fair Market Value at the time of the Option
surrender equal to the dollar amount by which the then Fair Market Value of the Shares subject to the surrendered portion exceeds the aggregate Exercise Price payable for those Shares. Shares used to exercise an Option shall have been held by the
Grantee for the requisite period of time necessary to avoid adverse accounting consequences to the Company with respect to the Option. Payment for the Shares to be issued or transferred pursuant to the Option, and any required withholding taxes,
must be received by the Company by the time specified by the Compensation Committee depending on the type of payment being made, but in all cases prior to the issuance or transfer of such Shares. 

(f) Grants to Non-Exempt Employees. Notwithstanding the foregoing, Options granted to persons who are non-exempt employees under
the Fair Labor Standards Act of 1938, as amended, may not be exercisable for at least six months after the date of grant (except that such Options may become exercisable, as determined by the Compensation Committee, upon the Grantee’s death,
Disability or retirement, or upon a Change in Control or other circumstances permitted by applicable regulations). 
 Section 6. Stock
Awards 
 The Compensation Committee may issue or transfer Shares to an Employee, Advisor or member of the Board under a
Stock Award, upon such terms as the Compensation Committee deems appropriate. The following provisions are applicable to Stock Awards: 
 (a) General Requirements. Shares issued or transferred pursuant to Stock Awards may be issued or transferred for consideration or for no consideration, and subject to restrictions or no
restrictions, as determined by the Compensation Committee. The Compensation Committee may, but shall not be required to, establish conditions under which restrictions on Stock Awards shall lapse over a period of time or according to such other
criteria as the 

  
 8 

 
Compensation Committee deems appropriate, including, without limitation, restrictions based upon the achievement of specific performance goals. The period of time during which the Stock Awards
will remain subject to restrictions will be designated in the Grant Letter as the “Restriction Period.” 
 (b)
Number of Shares. The Compensation Committee shall determine the number of Shares to be issued or transferred pursuant to a Stock Award and the restrictions applicable to such Shares. 

(c) Requirement of Employment or Service. If the Grantee is no longer employed or engaged by the Company or any Affiliate during a
period designated in the Grant Letter as the Restriction Period, or if other specified conditions are not met, the Stock Award shall terminate as to all Shares covered by the Grant as to which the restrictions have not lapsed, and those Shares must
be immediately returned to the Company. The Compensation Committee may, however, provide for complete or partial exceptions to this requirement as it deems appropriate. 
 (d) Restrictions on Transfer and Legend on Stock Certificate. During the Restriction Period, a Grantee may not sell, assign, transfer, pledge or otherwise dispose of the Shares of a Stock Award
except under Section 14(b) below. Unless otherwise determined by the Compensation Committee, the Company will retain possession of certificates for Shares of Stock Awards until all restrictions on such Shares have lapsed. Each certificate for a
Stock Award, unless held by the Company, shall contain a legend giving appropriate notice of the restrictions in the Grant. The Grantee shall be entitled to have the legend removed from the stock certificate covering the Shares subject to
restrictions when all restrictions on such Shares have lapsed. The Compensation Committee may determine that the Company will not issue certificates for Stock Awards until all restrictions on such Shares have lapsed. 

(e) Right to Vote and to Receive Dividends. Unless the Compensation Committee determines otherwise, during the Restriction Period,
the Grantee shall have the right to vote Shares of Stock Awards and to receive any dividends or other distributions paid on such Shares, subject to any restrictions deemed appropriate by the Compensation Committee, including, without limitation, the
achievement of specific performance goals. 
 (f) Lapse of Restrictions. All restrictions imposed on Stock Awards shall
lapse upon the expiration of the applicable Restriction Period and the satisfaction of all conditions, if any, imposed by the Compensation Committee. The Compensation Committee may determine, as to any or all Stock Awards, that the restrictions
shall lapse without regard to any Restriction Period. 

  
 9 

 Section 7. Stock Units 
 The Compensation Committee may grant Stock Units, each of which shall represent one hypothetical Share, to an Employee, Advisor or member of the Board, upon such terms and conditions as the Compensation
Committee deems appropriate. The following provisions are applicable to Stock Units: 
 (a) Crediting of Units. Each
Stock Unit shall represent the right of the Grantee to receive a Share or an amount of cash based on the value of a Share, if and when specified conditions are met. All Stock Units shall be credited to bookkeeping accounts established on the
Company’s records for purposes of the Plan. 
 (b) Terms of Stock Units. The Compensation Committee may grant Stock
Units that are payable if specified performance goals or other conditions are met, or under other circumstances. Stock Units may be paid at the end of a specified performance period or other period, or payment may be deferred to a date authorized by
the Compensation Committee. The Compensation Committee shall determine the number of Stock Units to be granted and the requirements applicable to such Stock Units. 
 (c) Requirement of Employment or Service. If the Grantee is no longer employed or engaged by the Company or any Affiliate prior to the vesting of Stock Units, or if other conditions established by
the Compensation Committee are not met, the Grantee’s Stock Units shall be forfeited. The Compensation Committee may, however, provide for complete or partial exceptions to this requirement as it deems appropriate. 

(d) Payment With Respect to Stock Units. Payments with respect to Stock Units shall be made in cash, Shares or any combination of
the foregoing, as the Compensation Committee shall determine. 
 Section 8. Stock Appreciation Rights 

The following provisions are applicable to SARs: 
 (a) General Requirements. The Compensation Committee may grant SARs to an Employee, Advisor or member of the Board separately or in tandem with any Option (for all or a portion of the applicable
Option). Tandem SARs may be granted either at the time the Option is granted or at any time thereafter while the Option remains outstanding; provided, however, that, in the case of an ISO, SARs may be granted only at the time of the
grant of the ISO. The Compensation Committee shall establish the base amount of the SAR at the time the SAR is granted, which shall be equal to or greater than the Fair Market Value of a Share as of the date of grant of the SAR. The base amount of
each SAR shall be equal to the per Share Exercise Price of the related Option, provided such Exercise Price is equal to or greater than the Fair Market Value of a Share as of the date of grant of the SAR or, if there is no related Option, an amount
equal to or greater than the Fair Market Value of a Share as of the date of grant of the SAR. 
 (b) Tandem SARs. In the
case of tandem SARs, the number of SARs granted to a Grantee that shall be exercisable during a specified period shall not exceed the number of Shares that the Grantee may purchase upon the exercise of the related Option during such period. Upon the
exercise of an Option, the SARs relating to the Shares covered by such Option shall terminate. Upon the exercise of SARs, the related Option shall terminate to the extent of an equal number of Shares. 

  
 10 

 (c) Exercisability. A SAR shall be exercisable during the period specified by the
Compensation Committee in the Grant Letter and shall be subject to such vesting and other restrictions as may be specified in the Grant Letter. The Compensation Committee may accelerate the exercisability of any or all outstanding SARs at any time
for any reason. SARs may only be exercised while the Grantee is employed or engaged by the Company or Affiliate or during the applicable period after termination of employment or engagement as described in Section 5(c) above. A tandem SAR shall
be exercisable only during the period when the Option to which it is related is also exercisable. 
 (d) Grants to Non-Exempt
Employees. Notwithstanding the foregoing, SARs granted to persons who are non-exempt employees under the Fair Labor Standards Act of 1938, as amended, may not be exercisable for at least six months after the date of grant (except that such SARs
may become exercisable, as determined by the Compensation Committee, upon the Grantee’s death, Disability or retirement, or upon a Change in Control or other circumstances permitted by applicable regulations). 

(e) Value of SARs. When a Grantee exercises SARs, the Grantee shall receive in settlement of such SARs an amount equal to the
value of the stock appreciation for the number of SARs exercised. The stock appreciation for a SAR is the amount by which the Fair Market Value of the underlying Share on the date of exercise of the SAR exceeds the base amount of the SAR as
described in subsection (a) above. 
 (f) Form of Payment. The appreciation in a SAR shall be paid in Shares, cash
or any combination of the foregoing, as the Compensation Committee shall determine. For purposes of calculating the number of Shares to be received, Shares shall be valued at their Fair Market Value on the date of exercise of the SAR. 

Section 9. Other Stock-Based Awards 
 The Compensation Committee may grant Other Stock-Based Awards, which are awards (other than those described in Sections 5, 6, 7 and 8 of the Plan) that are based on or measured by Shares, to any Employee,
Advisor or member of the Board, on such terms and conditions as the Compensation Committee shall determine. Other Stock-Based Awards may be awarded subject to the achievement of performance goals or other conditions and may be payable in cash,
Company Stock or any combination of the foregoing, as the Compensation Committee shall determine. 
 Section 10. Dividend
Equivalents 
 The Compensation Committee may grant Dividend Equivalents in connection Stock Units or Other Stock-Based
Awards. Dividend Equivalents may be paid currently or accrued as contingent cash obligations and may be payable in cash or Shares, and upon such terms as the Compensation Committee may establish, including, without limitation, the achievement of
specific performance goals. 

  
 11 

 Section 11. Qualified Performance-Based Compensation 

The Compensation Committee may determine that Stock Awards, Stock Units, Other Stock-Based Awards and Dividend Equivalents granted to an
Employee shall be considered “qualified performance-based compensation” under Code section 162(m). The following provisions shall apply to Grants of Stock Awards, Stock Units, Other Stock-Based Awards and Dividend Equivalents that are to
be considered “qualified performance-based compensation” under Code section 162(m): 
 (a) Performance Goals.

 (i) When Stock Awards, Stock Units, Other Stock-Based Awards or Dividend Equivalents that are to be considered
“qualified performance-based compensation” are granted, the Compensation Committee shall establish in writing (i) the objective performance goals that must be met, (ii) the performance period during which the performance will be
measured, (iii) the threshold, target and maximum amounts that may be paid if the performance goals are met, and (iv) any other conditions that the Compensation Committee deems appropriate and consistent with the Plan and Code section
162(m). 
 (ii) The business criteria may relate to the Grantee’s business unit or the performance of the Company and its
parents and subsidiaries as a whole, or any combination of the foregoing. The Compensation Committee shall use objectively determinable performance goals based on one or more of the following criteria: stock price, earnings per share, net earnings,
operating earnings, earnings before income taxes, EBITDA (earnings before income tax expense, interest expense, and depreciation and amortization expense), return on assets, shareholder return, return on equity, growth in assets, unit volume, sales
or market share, or strategic business criteria consisting of one or more objectives based on meeting specified revenue goals, market penetration goals, geographic business expansion goals, cost targets or goals relating to acquisitions or
divestitures. 
 (b) Establishment of Goals. The Compensation Committee shall establish the performance goals in writing
either before the beginning of the performance period or during a period ending no later than the earlier of (i) 90 days after the beginning of the performance period or (ii) the date on which 25% of the performance period has been
completed, or such other date as may be required or permitted under applicable regulations under Code section 162(m). The performance goals shall satisfy the requirements for “qualified performance-based compensation,” including the
requirement that the achievement of the goals be substantially uncertain at the time they are established and that the goals be established in such a way that a third party with knowledge of the relevant facts could determine whether and to what
extent the performance goals have been met. The Compensation Committee shall not have discretion to increase the amount of compensation that is payable upon achievement of the designated performance goals. 

(c) Announcement of Grants. The Compensation Committee shall certify and announce the results for each performance period to all
Grantees after the announcement of the Company’s financial results for the performance period. If and to the extent that the 

  
 12 

 
Compensation Committee does not certify that the performance goals have been met, the grants of Stock Awards, Stock Units, Other Stock-Based Awards and Dividend Equivalents for the performance
period shall be forfeited or shall not be made, as applicable. If Dividend Equivalents are granted as “qualified performance-based compensation” under Code section 162(m), a Grantee may not accrue more than $1,000,000 of such Dividend
Equivalents during any calendar year. 
 (d) Death, Disability or Other Circumstances. The Compensation Committee may
provide that Stock Awards, Stock Units, Other Stock-Based Awards and Dividend Equivalents shall be payable or restrictions on such Grants shall lapse, in whole or in part, in the event of the Grantee’s death or Disability during the performance
period, or under other circumstances consistent with the Treasury regulations and rulings under Code section 162(m). 
 Section 12.
Deferrals 
 The Compensation Committee may permit or require a Grantee to defer receipt of the payment of cash or the
delivery of Shares that would otherwise be due to such Grantee in connection with any Stock Units or Other Stock-Based Awards. If any such deferral election is permitted or required, the Compensation Committee shall establish rules and procedures
for such deferrals and may provide for interest or other earnings to be paid on such deferrals. The rules and procedures for any such deferrals shall be consistent with applicable requirements of Code section 409A. 

Section 13. Adjustment Upon Changes in Capitalization. 
 In the event any recapitalization, forward or reverse split, reorganization, merger, consolidation, spin-off, combination, repurchase, exchange or issuance of Shares or other securities, any stock
dividend or other special and nonrecurring dividend or distribution (whether in the form of cash, securities or other property), liquidation, dissolution, or other similar transactions or events, affects the Shares, then the Compensation Committee
shall make such adjustment, in such manner as the Compensation Committee deems appropriate, in order to prevent dilution or enlargement of the rights of Grantees under the Plan, including adjustment in (i) the number and kind of Shares deemed
to be available thereafter for Grants under Section 3, (ii) the number and kind of Shares that may be delivered or deliverable in respect of outstanding Grants, and (iii) the price per share or the applicable market value of such
Grants. In addition, the Compensation Committee shall make such adjustments as are appropriate in the terms and conditions of, and the criteria included in, Grants (including, without limitation, cancellation of Grants in exchange for the
in-the-money value, if any, of the vested portion thereof, cancellation of unvested Grants for no consideration, cancellation of out-of-the-money Grants for no consideration, substitution of Grants using securities of a successor or other entity,
acceleration of the time that Grants expire, or adjustment of performance targets) in recognition of unusual or nonrecurring events (including, without limitation, a Change in Control or an event described in the preceding sentence) affecting the
Company or any Affiliate of the Company or the financial statements of the Company or any Affiliate of the Company, or in response to changes in applicable laws, regulations or accounting principles. Any adjustments to outstanding Grants shall be
consistent with Code section 409A or 424, to the extent applicable. Any adjustments determined by the Compensation Committee shall be final, binding and conclusive. 

  
 13 

 Section 14. Restrictions on Shares. 

(a) Restrictions on Issuing Shares. No Shares shall be issued or transferred under the Plan unless and until all applicable legal
requirements have been complied with to the satisfaction of the Compensation Committee. The Compensation Committee shall have the right to condition any Grant on the Grantee’s undertaking in writing to comply with such restrictions on any
subsequent disposition of the Shares issued or transferred thereunder as the Compensation Committee shall deem necessary or advisable as a result of any applicable law, regulation or official interpretation thereof. 

(b) Transfer Restrictions. 
 (i) Nontransferability of Options. Except as provided below, only the Grantee may exercise rights under a Grant during the Grantee’s lifetime. A Grantee may not transfer those rights except
(A) by will or by the laws of descent and distribution or (B) with respect to Grants other than ISOs, pursuant to a domestic relations order. When a Grantee dies, the personal representative or other Person entitled to succeed to the
rights of the Grantee may exercise such rights. Any such successor must furnish proof satisfactory to the Company of his or her right to receive the Grant under the Grantee’s will or under the applicable laws of descent and distribution.

 (ii) Transfer of Nonqualified Stock Options. Notwithstanding (i) above, the Compensation Committee may provide,
in a Grant Letter, that a Grantee may transfer Nonqualified Options to family members, or one or more trusts or other entities for the benefit of or owned by family members, consistent with the applicable securities laws, according to such terms as
the Compensation Committee may determine; provided that the Grantee receives no consideration for the transfer of the Nonqualified Option and the transferred Nonqualified Option shall continue to be subject to the same terms and conditions as were
applicable to the Nonqualified Option immediately before the transfer. 
 (c) ISO Notice. A Grantee shall notify the
Company of any disposition of Shares acquired upon exercise of an ISO if such disposition occurs within one year of the date of such exercise or within two years of the date of grant of such ISO. The Company may impose such procedures as it
determines may be necessary to ensure that such notification is made. 
 (d) Requirements for Issuance or Transfer of
Shares. No Shares shall be issued or transferred in connection with any Grant made hereunder unless and until all legal requirements applicable to the issuance or transfer of such Shares have been complied with to the satisfaction of the
Compensation Committee. The Compensation Committee shall have the right to condition any Grant on the Grantee’s undertaking in writing to comply with such restrictions on his or her subsequent disposition of the Shares as the Compensation
Committee shall deem necessary or advisable, and certificates representing such Shares may be legended to reflect any such restrictions. Certificates representing Shares issued or transferred under the Plan may be subject to such stop-transfer
orders and other restrictions as the Compensation Committee deems appropriate to comply with applicable laws, regulations and interpretations, including any requirement that a legend be placed thereon. 

  
 14 

 Section 15. Withholding of Taxes. 

All Grants made under the Plan shall be subject to applicable federal (including FICA), state and local tax withholding requirements. The
Company may require that the Grantee or other Person receiving or exercising Grants pay to the Company or any Affiliate the amount of any federal, state or local taxes that the Company or any Affiliate is required to withhold with respect to such
Grants, or the Company or any Affiliate may deduct from other wages paid by the Company or any Affiliate the amount of any withholding taxes due with respect to such Grants. If the Compensation Committee so permits, a Grantee may elect to satisfy
the applicable tax withholding obligation with respect to a Grant by having Shares withheld up to an amount that does not exceed the Grantee’s minimum applicable withholding tax rate for federal (including FICA), state and local tax
liabilities. The election must be in a form and manner prescribed by the Compensation Committee and may be subject to the prior approval of the Compensation Committee. 
 Section 16. Consequences of a Change in Control. 
 (a) Notice and
Acceleration. Unless the Compensation Committee determines otherwise, effective upon the date of the Change in Control, (i) all outstanding Options and SARs shall automatically accelerate and become fully exercisable, (ii) the
restrictions and conditions on all outstanding Stock Awards shall immediately lapse, and (iii) all Stock Units, Other Stock-Based Awards and Dividend Equivalents shall become fully vested and shall be paid at their target values, or in such
greater amounts as the Compensation Committee may determine. 
 (b) Other Alternatives. Notwithstanding the foregoing, in
the event of a Change in Control, in addition to the actions described in Section 13, the Compensation Committee may take one or more of the following actions with respect to any or all outstanding Grants: the Compensation Committee may
(i) require that Grantees surrender their outstanding vested Options and SARs in exchange for one or more payments by the Company, in cash or Shares as determined by the Compensation Committee, in an amount equal to the amount by which the then
Fair Market Value of the Shares subject to the Grantee’s unexercised, vested Options and SARs exceeds the Exercise Price of the vested Options or the base amount of the vested SARs, as applicable, (ii) provide for the cancellation of
unvested Grants for no consideration, (iii) provide for the cancellation of out-of-the-money Grants for no consideration, (iv) after giving Grantees an opportunity to exercise their outstanding Options and SARs, terminate any or all
unexercised Options and SARs at such time as the Compensation Committee deems appropriate, or (v) determine that outstanding Options and SARs that are not exercised shall be assumed by, or replaced with comparable options or rights by, the
surviving corporation, (or a parent or subsidiary of the surviving corporation), and other outstanding Grants that remain in effect after the Change in Control shall be converted to similar grants of the surviving corporation (or a parent or
subsidiary of the surviving corporation). Such surrender or termination shall take place as of the date of the Change in Control or such other date as the Compensation Committee may specify. 

  
 15 

 Section 17. General Provisions 

(a) Grant Letter. Each Grant shall be evidenced by a Grant Letter. The terms and provisions of such Grant Letters may vary among
Grantees and among different Grants made to the same Grantee. 
 (b) No Right to Employment. The making of a Grant in any
year shall not give the Grantee any right to similar grants in future years, any right to continue such Grantee’s employment relationship with the Company or its Affiliates, or, until Shares are issued, any rights as a stockholder of the
Company. All Grantees shall remain subject to discharge to the same extent as if the Plan were not in effect. For purposes of the Plan, a sale of any Affiliate of the Company that employs or engages a Grantee shall be treated as the termination of
such Grantee’s employment or engagement, unless the Grantee shall otherwise continue to provide services to the Company or another subsidiary of the Company as an employee or director. 

(c) No Fractional Shares. No fractional Shares shall be issued or delivered pursuant to the Plan or any Grant. Except as otherwise
provided under the Plan, the Compensation Committee shall determine whether cash, other awards or other property shall be issued or paid in lieu of such fractional Shares or whether such fractional Shares or any rights thereto shall be forfeited or
otherwise eliminated. 
 (d) No Funding. No Grantee, and no beneficiary or other Persons claiming under or through the
Grantee, shall have any right, title or interest by reason of any Option to any particular assets of the Company or Affiliates of the Company, or any Shares allocated or reserved for the purposes of the Plan or subject to any Grant except as set
forth herein. The Company shall not be required to establish any fund or make any other segregation of assets to assure satisfaction of the Company’s obligations under the Plan. 

(e) Governing Law; Jurisdiction. The Plan shall be governed by and construed in accordance with the laws of the State of Delaware,
without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware. To the
extent the Grantee is a party to an employment agreement with the Company or any of its subsidiaries that provides for binding arbitration of employment disputes, then any disputes between the Company and such Grantee arising under the Plan shall be
arbitrated in accordance with the procedures set forth in such employment agreement. 
 (f) Compliance with Law. The
Plan, the exercise of Options and SARs and the obligations of the Company to issue or transfer Shares under Grants shall be subject to all applicable laws and regulations, and to approvals by any governmental or regulatory agency as may be required.
With respect to Persons subject to section 16 of the Exchange Act, it is the intent of the Company that the Plan and all transactions under the Plan comply with all applicable provisions of Rule 16b-3 or its successors under the Exchange Act. In
addition, it is 

  
 16 

 
the intent of the Company that ISOs comply with the applicable provisions of Code section 422, that the Plan comply with the applicable provisions of Code section 162(m) and that, to the extent
applicable, Grants be exempt from or comply with the requirements of Code section 409A. Notwithstanding the foregoing, the Committee makes no representation that the Grants awarded under the Plan shall be exempt from or comply with Code section 409A
and makes no undertaking to preclude Code section 409A from applying to Grants awarded under the Plan. To the extent that any legal requirement of section 16 of the Exchange Act or Code sections 422, 162(m) or 409A as set forth in the Plan ceases to
be required under section 16 of the Exchange Act or Code sections 422, 162(m) or 409A, that Plan provision shall cease to apply. To the extent applicable, if on the date of a Grantee’s “separation from service” (as such term is
defined under Code section 409A), Shares (or shares of any other company required to be aggregated with the Company for purposes of Code section 409A and its corresponding regulations) are publicly-traded on an established securities market or
otherwise and the Grantee is a “specified employee” (as such term is defined in Code section 409A(a)(2)(B)(i) and its corresponding regulations) as determined by the Committee (or its delegate) in its discretion in accordance with the
requirements of Code sections 409A and 416, then all Grants that are deemed to be deferred compensation subject to the requirements of Code section 409A and payable within six months following such Grantee’s “separation from service”
shall be postponed for a period of six months following the Grantee’s “separation from service” with the Company. The Compensation Committee may revoke any Grant if it is contrary to law or modify a Grant to bring it into compliance
with any valid and mandatory government regulation. The Committee may, in its sole discretion, agree to limit its authority under this Section 
 (g) Grants made in Connection with Corporate Transactions and Otherwise. Nothing contained in the Plan shall be construed to (i) limit the right of the Compensation Committee to make Grants
under the Plan in connection with the acquisition, by purchase, lease, merger, consolidation or otherwise, of the business or assets of any corporation, firm or association, including Grants to employees thereof who become Employees, or
(ii) limit the right of the Company to grant stock options or make other awards outside of the Plan. The Compensation Committee may make a Grant to an employee of another corporation who becomes an Employee by reason of a corporate merger,
consolidation, acquisition of stock or property, reorganization or liquidation involving the Company, in substitution for awards made by such corporation. Notwithstanding anything in the Plan to the contrary, the Compensation Committee may establish
such terms and conditions of the new Grants as it deems appropriate, including setting the Exercise Price of Options at a price necessary to retain for the Grantee the same economic value as the prior options. 

(h) Application of Company Clawback Policy. All Grants under the Plan are subject to the applicable provisions of the
Company’s clawback or recoupment policy approved by the Board or the Compensation Committee; as such policy may be in effect from time to time. 
 Section 18. Amendment or Termination. 
 (a) Amendment. The Board
may amend or terminate the Plan at any time; provided, however, that the Board shall not amend the Plan without stockholder approval if such approval is required in order to comply with the Code or other applicable law, or to comply with applicable
stock exchange requirements. 

  
 17 

 (b) No Repricing Without Stockholder Approval. Notwithstanding anything in the Plan
to the contrary, the Compensation Committee may not reprice Options or SARs, nor may the Board amend the Plan to permit repricing of Options or SARs, unless the stockholders of the Company provide prior approval for such repricing. The term
“repricing” shall have the meaning given that term in accordance with the applicable stock exchange in which such shares of Company Stock are registered, as in effect from time to time; provided that an adjustment to an Option or SAR
pursuant to Section 13 above shall not constitute a repricing of the Option or SAR. 
 (c) Stockholder
Re-Approval Requirement. If Stock Awards, Stock Units, Other Stock-Based Awards or Dividend Equivalents are granted as “qualified performance-based compensation” under Section 11 above, the Plan must be reapproved by the
stockholders no later than the first stockholders meeting that occurs in the fifth year following the year in which the stockholders previously approved the provisions of Section 11, if required by Code section 162(m) or the regulations
thereunder. 
 (d) Termination of Plan. The Plan shall terminate on December 8, 2018, unless the Plan
is terminated earlier by the Board or is extended by the Board with the approval of the stockholders. 
 (e)
Termination and Amendment of Outstanding Grants. A termination or amendment of the Plan that occurs after a Grant is made shall not materially impair the rights of a Grantee unless the Grantee consents or unless the Compensation Committee
acts under Section 17(f) above. The termination of the Plan shall not impair the power and authority of the Compensation Committee with respect to an outstanding Grant. Whether or not the Plan has terminated, an outstanding Grant may be
terminated or amended under Section 17(f) above or may be amended by agreement of the Company and the Grantee consistent with the Plan. 

  
 18Sixth Loan Modification Agreement

 Exhibit 10.1 

SIXTH LOAN MODIFICATION AGREEMENT 
 This Sixth Loan Modification Agreement (this “Loan Modification Agreement”) is entered into and effective as of March 29, 2013 (the “Sixth Loan Modification Effective
Date”), by and between (i) SILICON VALLEY BANK, a California corporation, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production office located at 380 Interlocken
Crescent, Suite 600, Broomfield, Colorado 80021 (“Bank”), (ii) ATRICURE, INC., a Delaware corporation with its chief executive office located at 6217 Centre Park Drive, West Chester, Ohio 45069
(“Atricure”), and (iii) ATRICURE, LLC, a Delaware limited liability company (“Atricure LLC”, and together with Atricure, individually and collectively, jointly and severally, the
“Borrower”). 
 1. DESCRIPTION OF EXISTING INDEBTEDNESS AND OBLIGATIONS. Among other indebtedness and obligations which
may be owing by Borrower to Bank, Borrower is indebted to Bank pursuant to a loan arrangement dated as of September 13, 2010, evidenced by, among other documents, a certain Amended and Restated Loan and Security Agreement dated as of
September 13, 2010, between Borrower and Bank, as further amended by a certain First Loan Modification Agreement entered into and effective as of March 15, 2011, as further amended by a certain Second Loan Modification Agreement, entered
into and effective as of February 2, 2012, as further amended by a certain Third Loan Modification Agreement, dated as of May 31, 2012, as further amended by a certain Fourth Loan Modification Agreement, dated as of September 26, 2012
and as further amended by a certain Joinder and Fifth Loan Modification Agreement, dated as of January 30, 2013 (as amended, the “Loan Agreement”). Capitalized terms used but not otherwise defined herein shall have the same
meaning as in the Loan Agreement. 
 2. DESCRIPTION OF COLLATERAL. Repayment of the Obligations is secured by the Collateral as described
(i) in the Loan Agreement; (ii) in a certain Export-Import Bank Loan and Security Agreement, dated as of September 13, 2010, as further amended by a certain Export-Import Bank First Loan Modification Agreement entered into and
effective as of March 15, 2011, as further amended by a certain Export-Import Bank Second Loan Modification Agreement, dated as of February 2, 2012, and as further amended by a certain Export-Import Bank Joinder and Third Loan Modification
Agreement, dated as of January 30, 2013 (as amended, the “EXIM Loan Agreement”); (iii) in a certain Intellectual Property Security Agreement dated as of May 1, 2009 (the “IP Agreement”); and
(iv) a certain Unconditional Guaranty dated as of September 26, 2012, a certain Guarantor Security Agreement, dated as of September 26, 2012 and the Dutch Security Documents, in each case executed by Atricure Europe, B.V., a company
organized under the laws of The Netherlands and a wholly owned Subsidiary of Borrower (the documents described in the foregoing clauses (i) through (iv), together with any other collateral security granted to Bank, are collectively referred to
as the “Security Documents”). 
 Hereinafter, the Security Documents, together all other documents evidencing or securing the
Obligations shall be referred to as the “Existing Loan Documents”. 
  

	3.	DESCRIPTION OF CHANGE IN TERMS. 

  

	 	A.	Modifications to Loan Agreement. 

  

	 	1	The Loan Agreement shall be amended by deleting the following text appearing as Section 2.3(a) thereof: 

 

	 	“(a)	Interest Rate. 

 (i)
Advances. Subject to Section 2.3(b), the principal amount of Advances outstanding under the Revolving Line shall accrue interest at a floating per annum rate based on Borrower’s Liquidity Ratio (and the existence or non-existence of
an Event of Default) as set forth below, which interest shall be payable monthly, in arrears, in accordance with Section 2.3(f) below. 

			
	 Liquidity Ratio as of the end of a

month and Event of Default status
	  	 Interest Rate

	Greater than or equal to 2.50:1.00, and no Event of Default has occurred and is continuing	  	One-quarter of one percentage point (0.25%) above the Base Rate (the “First Tier Rate”)
		
	Greater than or equal to 2.00:1.00, but less than 2.50:1.00, and no Event of Default has occurred and is continuing	  	Three-quarters of one percentage point (0.75%) above the Base Rate (the “Second Tier Rate”)
		
	Less than 2.00:1.00, or an Event of Default has occurred and is continuing	  	One and one-quarter percentage points (1.25%) above the Base Rate (the “Regular Rate”)

 The rate in effect as of the Second Loan Modification Effective Date is the Second Tier Rate. Changes in
the interest rate based on the Borrower’s Liquidity Ratio as provided above shall go into effect as of the first day of the month following the month in which Borrower’s financial statements are received by Bank. If, based on the Liquidity
Ratio as shown in Borrower’s financial statements, there is to be an increase in the interest rate, the interest rate increase may be put into effect by Bank as of the first day of the month following the month in which Borrower’s
financial statements were due, even if the delivery of the financial statements is delayed. The Regular Rate shall go into effect immediately upon the occurrence and during the continuance of an Event of Default unless Bank otherwise elects from
time to time in its sole discretion to delay its effect or impose a smaller increase. 
 (ii) Term Loan 2012. Subject to
Section 2.3(b), the principal amount outstanding under the Term Loan 2012 shall accrue interest at a per annum rate equal to six and three quarters percent (6.75%), which interest shall be payable monthly in accordance with
Section 2.1.7(c).” 
 and inserting in lieu thereof the following: 

“(a) Interest Rate. 
 (i) Advances. Subject to Section 2.3(b), the principal amount of Advances outstanding under the Revolving Line shall accrue interest at a floating per annum rate equal to the Prime Rate plus
one and one-quarter percent (1.25%); provided, that while a Streamline Period is in effect, the principal amount of Advances outstanding under the Revolving Line shall accrue interest at a floating per annum rate equal to the Prime
Rate, which interest shall in any event be payable monthly, in arrears, in accordance with Section 2.3(f) below. 
 (ii)
Term Loan 2012. Subject to Section 2.3(b), the principal amount outstanding under the Term Loan 2012 shall accrue interest at a per annum rate equal to four and three quarters percent (4.75%), which interest shall be payable monthly in
accordance with Section 2.1.7(c).” 
  

	 	2	The Loan Agreement shall be amended by deleting the following text appearing as Section 2.4(f) thereof: 

“(f) Collateral Monitoring Fee. A collateral monitoring fee of One Thousand Dollars ($1,000) for each month during which the
Streamline Period is not in effect for the entire month and of Five Hundred Dollars ($500) for each month during which the Streamline Period is in effect for the entire month, payable in arrears on the last day of each month (prorated for any
partial month at the beginning and upon termination of this Agreement); and” 
 and inserting in lieu thereof the
following: 

  
 2 

 “(f) Collateral Monitoring Fee. A collateral monitoring fee of One Thousand
Dollars ($1,000) for each month during which the Streamline Period is not in effect for the entire month and of Zero Dollars ($0.00) for each month during which the Streamline Period is in effect for the entire month, payable in arrears on the last
day of each month (prorated for any partial month at the beginning and upon termination of this Agreement); and” 
  

	 	3	The Loan Agreement shall be amended by deleting the following text appearing as Section 6.9(a) thereof: 

“(a) Minimum Liquidity Ratio. A Liquidity Ratio of at least 1.75 to 1.00 at all times, it being understood that Quarter-end
Advances shall be excluded from the foregoing calculation; provided, however, that the foregoing Liquidity Ratio covenant will no longer be tested (other than to determine the interest rate applicable to the Revolving Line as described
in Section 2.3(a)), for any period commencing on the date that Borrower provides Bank evidence satisfactory to Bank, in its reasonable discretion, that Borrower has achieved a Fixed Charge Coverage Ratio, measured on a trailing twelve month
basis, as of the last day of each of the immediately preceding four consecutive fiscal quarters of greater than 1.50:1.00 (the “FCCR Triggering Event”).” 

and inserting in lieu thereof the following: 
 “(a) Minimum Liquidity Ratio. A Liquidity Ratio of at least 2.00 to 1.00 at all times, it being understood that Quarter-end Advances shall be excluded from the foregoing calculation;
provided, however, that the foregoing Liquidity Ratio covenant will no longer be tested for any period commencing on the date that Borrower provides Bank evidence satisfactory to Bank, in its reasonable discretion, that Borrower has
achieved a Fixed Charge Coverage Ratio, measured on a trailing twelve month basis, as of the last day of each of the immediately preceding four consecutive fiscal quarters of greater than 1.50:1.00 (the “FCCR Triggering
Event”).” 
  

	 	4	The Loan Agreement shall be amended by deleting the following text appearing as Section 6.9(d) thereof: 

“(d) Minimum EBITDA. Achieve, measured as of the end of each month, for the trailing six-month period ending as of the end of
such month, EBITDA of at least the following minimum amounts for the months ending during the following periods (amounts in parentheses below represent negative numbers): 

 

					
	Period	  	Minimum EBITDA	 
	 December 31, 2012 through and including January 31, 2013
	  	 	($3,000,000	) 
		
	 February 29, 2013 through and including April 30, 2013
	  	 	($3,500,000	) 
		
	 May 31, 2013 through and including June 30, 2013
	  	 	($3,000,000	) 
		
	 July 31, 2013 through and including August 31, 2013
	  	 	($2,500,000	) 
		
	 September 30, 2013 through and including October 31, 2013
	  	 	($1,000,000	) 
		
	 November 30, 2013 and each monthly period ending thereafter
	  	$	1.00”	  

  
 3 

	 	    	and inserting in lieu thereof the following: 

  

	 	    	“(d) Minimum EBITDA. For any monthly period commencing March 1, 2013 through and including December 31, 2013 in which Borrower fails to maintain
unrestricted cash and Cash Equivalents at Bank in an amount equal to or greater than Twenty Million Dollars ($20,000,000) for each day in such monthly period, Borrower shall achieve, measured as of the end of each month, for the trailing six-month
period ending as of the end of such month, EBITDA no worse than negative Four Million Dollar ($4,000,000). Financial covenant levels for the fiscal year commencing January 1, 2014 shall be mutually determined by Borrower and Bank based on the
Borrower’s annual forecast for such fiscal year. 

  

	 	5	The Loan Agreement shall be amended by inserting the following definition in its appropriate alphabetical order in Section 13.1 thereof: 

 

	 	    	““Sixth Loan Modification Effective Date” is March 29, 2013.” 

 

	 	6	The Loan Agreement shall be amended by deleting the following definition appearing in Section 13.1 thereof: 

 

	 	    	“Base Rate” is the greater of the Prime Rate or 4.0% per annum.” 

 

	 	7	The Loan Agreement shall be amended by deleting Exhibit B attached thereto and inserting Exhibit A attached hereto in lieu thereof:

 4. CONDITIONS PRECEDENT. As a condition precedent to the effectiveness of this Loan Modification Agreement and the
Bank’s obligation to make further Advances under the Revolving Line, the Bank shall have received the following documents prior to or concurrently with this Loan Modification Agreement, each in form and substance satisfactory to the Bank:

  

	 	A.	this Loan Modification Agreement duly executed on behalf of each Borrower and signed by way of acknowledgement by Guarantor; 

 

	 	B.	copies, certified by a duly authorized officer of Borrower and Guarantor, to be true and complete as of the date hereof, of each of (i) the governing documents of
Borrower and Guarantor as in effect on the date hereof (but only to the extent modified since last delivered to the Bank), (ii) the resolutions of Borrower and Guarantor authorizing the execution and delivery of this Loan Modification
Agreement, the other documents executed in connection herewith and Borrower’s and Guarantor’s respective performance of all of the transactions contemplated hereby (but only to the extent required since last delivered to Bank), and
(iii) an incumbency certificate giving the name and bearing a specimen signature of each individual who shall be so authorized on behalf of Borrower and Guarantor (but only to the extent any signatories have changed since such incumbency
certificate was last delivered to Bank); 

  

	 	C.	a good standing certificate of each Borrower and Guarantor, certified by the Secretary of State of the state of incorporation of each respective Borrower and Guarantor,
together with a certificate of foreign qualification from the Secretary of State (or comparable governmental entity) of each state in which each Borrower and Guarantor is qualified to transact business as a foreign entity, if any, in each case dated
as of a date no earlier than thirty (30) days prior to the date hereof, in each case to the extent required by Bank; 

  

	 	D.	certified copies, dated as of a recent date, of financing statement and other lien searches of each Borrower and Guarantor, as Bank may request and which shall be
obtained by Bank, accompanied by written evidence (including any UCC termination statements) that the Liens revealed in any such searched either (i) will be terminated prior to or in connection with the Loan Modification Agreement, or
(ii) in the sole discretion of Bank, will constitute Permitted Liens; 

  
 4 

	 	E.	evidence satisfactory to Bank that the insurance policies required under the Loan Agreement are in full force and effect, together with appropriate evidence showing
lender loss payable and/or additional insured clauses or endorsements in favor of Bank; and 

  

	 	F.	such other documents as Bank may reasonably request. 

 5. FEES. Borrower shall pay to Bank a modification fee equal to Twelve Thousand Five Hundred Dollars ($12,500.00), which fee shall be due on the date hereof and shall be deemed fully earned and
non-refundable as of the date hereof. In addition, without duplication of the anniversary fees payable pursuant to the Second Loan Modification Agreement, dated as of February 2, 2012, Borrower shall pay to Bank an anniversary fee equal to
Fifty Thousand Dollars ($50,000) on May 1, 2013. Borrower shall also reimburse Bank for all reasonable legal fees and expenses incurred in connection with this amendment to the Existing Loan Documents. 

6. AUTHORIZATION TO FILE. Borrower hereby authorizes Bank to file UCC financing statements without notice to Borrower, with all appropriate
jurisdictions, as Bank deems appropriate, in order to further perfect or protect Bank’s interest in the Collateral, including a notice that any disposition of the Collateral, by either the Borrower or any other Person, shall be deemed to
violate the rights of the Bank under the Code. 
 7. CONSISTENT CHANGES. The Existing Loan Documents are hereby amended wherever
necessary to reflect the changes described above. 
 8. RATIFICATION OF LOAN DOCUMENTS. Borrower hereby ratifies, confirms, and reaffirms
all terms and conditions of all security or other collateral granted to the Bank, and confirms that the indebtedness secured thereby includes, without limitation, the Obligations. 
 9. NO DEFENSES OF BORROWER. Borrower hereby acknowledges and agrees that Borrower has no offsets, defenses, claims, or counterclaims against Bank with respect to the Obligations, or otherwise, and
that if Borrower now has, or ever did have, any offsets, defenses, claims, or counterclaims against Bank, whether known or unknown, at law or in equity, all of them are hereby expressly WAIVED and Borrower hereby RELEASES Bank from any liability
thereunder. 
 10. CONTINUING VALIDITY. Borrower understands and agrees that in modifying the existing Obligations, Bank is relying upon
Borrower’s representations, warranties, and agreements, as set forth in the Existing Loan Documents. Except as expressly modified pursuant to this Loan Modification Agreement, the terms of the Existing Loan Documents remain unchanged and in
full force and effect. Bank’s agreement to modifications to the existing Obligations pursuant to this Loan Modification Agreement in no way shall obligate Bank to make any future modifications to the Obligations. Nothing in this Loan
Modification Agreement shall constitute a satisfaction of the Obligations. It is the intention of Bank and Borrower to retain as liable parties all makers of Existing Loan Documents, unless the party is expressly released by Bank in writing. No
maker will be released by virtue of this Loan Modification Agreement. 
 11. RIGHT OF SET-OFF. In consideration of Bank’s agreement
to enter into this Loan Modification Agreement, Borrower hereby reaffirms and hereby grants to Bank, a lien, security interest and right of set off as security for all Obligations to Bank, whether now existing or hereafter arising upon and against
all deposits, credits, collateral and property, now or hereafter in the possession, custody, safekeeping or control of Bank or any entity under the control of Silicon Valley Bank (including a Bank subsidiary) or in transit to any of them. At any
time after the occurrence and during the continuance of an Event of Default, without demand or notice, Bank may set off the same or any part thereof and apply the same to any liability or obligation of Borrower even though unmatured and regardless
of the adequacy of any other collateral securing the loan. ANY AND ALL RIGHTS TO REQUIRE BANK TO EXERCISE ITS RIGHTS OR REMEDIES WITH RESPECT TO ANY OTHER COLLATERAL WHICH SECURES THE OBLIGATIONS, PRIOR TO EXERCISING ITS RIGHT OF SETOFF WITH RESPECT
TO SUCH DEPOSITS, CREDITS OR OTHER PROPERTY OF BORROWER, ARE HEREBY KNOWINGLY, VOLUNTARILY AND IRREVOCABLY WAIVED. 
 12.
CONFIDENTIALITY. Without limiting Section 12.10 of the Loan Agreement (which is and shall remain in full force and effect), Bank may use confidential information for the development of databases, reporting purposes, and market analysis,
so long as such confidential information is aggregated and anonymized prior to distribution unless otherwise expressly permitted by Borrower. The provisions of the immediately preceding sentence shall survive the termination of the Loan Agreement.

  
 5 

 13. JURISDICTION/VENUE. California law governs the Loan Documents, including, without limitation,
this Loan Modification Agreement without regard to principles of conflicts of law. Borrower and Bank each submit to the exclusive jurisdiction of the State and Federal courts in Santa Clara County, California; provided, however, that
nothing in this Agreement shall be deemed to operate to preclude Bank from bringing suit or taking other legal action in any other jurisdiction to realize on the Collateral or any other security for the Obligations, or to enforce a judgment or other
court order in favor of Bank. Borrower expressly submits and consents in advance to such jurisdiction in any action or suit commenced in any such court, and Borrower hereby waives any objection that it may have based upon lack of personal
jurisdiction, improper venue, or forum non conveniens and hereby consents to the granting of such legal or equitable relief as is deemed appropriate by such court. Borrower hereby waives personal service of the summons, complaints, and other process
issued in such action or suit and agrees that service of such summons, complaints, and other process may be made by registered or certified mail addressed to Borrower at the address set forth in, or subsequently provided by Borrower in accordance
with, Section 10 of the Loan Agreement and that service so made shall be deemed completed upon the earlier to occur of Borrower’s actual receipt thereof or three (3) days after deposit in the U.S. mails, proper postage prepaid.

 TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, BORROWER AND BANK EACH WAIVE THEIR RIGHT TO A JURY TRIAL OF ANY CLAIM
OR CAUSE OF ACTION ARISING OUT OF OR BASED UPON THIS LOAN MODIFICATION AGREEMENT, THE LOAN AGREEMENT, THE LOAN DOCUMENTS OR ANY CONTEMPLATED TRANSACTION, INCLUDING CONTRACT, TORT, BREACH OF DUTY AND ALL OTHER CLAIMS. THIS WAIVER IS A MATERIAL
INDUCEMENT FOR BOTH PARTIES TO ENTER INTO THIS AGREEMENT. EACH PARTY HAS REVIEWED THIS WAIVER WITH ITS COUNSEL. 
 WITHOUT INTENDING IN ANY
WAY TO LIMIT THE PARTIES’ AGREEMENT TO WAIVE THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY, if the above waiver of the right to a trial by jury is not enforceable, the parties hereto agree that any and all disputes or controversies of any nature
between them arising at any time shall be decided by a reference to a private judge, mutually selected by the parties (or, if they cannot agree, by the Presiding Judge of the Santa Clara County, California Superior Court) appointed in accordance
with California Code of Civil Procedure Section 638 (or pursuant to comparable provisions of federal law if the dispute falls within the exclusive jurisdiction of the federal courts), sitting without a jury, in Santa Clara County, California;
and the parties hereby submit to the jurisdiction of such court. The reference proceedings shall be conducted pursuant to and in accordance with the provisions of California Code of Civil Procedure §§ 638 through 645.1, inclusive. The
private judge shall have the power, among others, to grant provisional relief, including without limitation, entering temporary restraining orders, issuing preliminary and permanent injunctions and appointing receivers. All such proceedings shall be
closed to the public and confidential and all records relating thereto shall be permanently sealed. If during the course of any dispute, a party desires to seek provisional relief, but a judge has not been appointed at that point pursuant to the
judicial reference procedures, then such party may apply to the Santa Clara County, California Superior Court for such relief. The proceeding before the private judge shall be conducted in the same manner as it would be before a court under the
rules of evidence applicable to judicial proceedings. The parties shall be entitled to discovery which shall be conducted in the same manner as it would be before a court under the rules of discovery applicable to judicial proceedings. The private
judge shall oversee discovery and may enforce all discovery rules and orders applicable to judicial proceedings in the same manner as a trial court judge. The parties agree that the selected or appointed private judge shall have the power to decide
all issues in the action or proceeding, whether of fact or of law, and shall report a statement of decision thereon pursuant to California Code of Civil Procedure § 644(a). Nothing in this paragraph shall limit the right of any party at any
time to exercise self-help remedies, foreclose against collateral, or obtain provisional remedies. The private judge shall also determine all issues relating to the applicability, interpretation, and enforceability of this paragraph. 

14. COUNTERSIGNATURE. This Loan Modification Agreement shall become effective only when it shall have been executed by Borrower and Bank.

 [The remainder of this page is intentionally left blank] 

  
 6 

 This Loan Modification Agreement is executed as of the Sixth Loan Modification Effective
Date. 
  

									
	BORROWER:	 		 	BANK:
			
	ATRICURE, INC.	 		 	SILICON VALLEY BANK
					
	By:	 	/s/ M. Andrew Wade	 		 	By:	 	/s/ Tom Hertzberg
	Name:	 	M. Andrew Wade	 		 	Name:	 	Tom Hertzberg
	Title:	 	Chief Financial Officer	 		 	Title:	 	Vice President II
				
	ATRICURE, LLC	 		 		 	
					
	By:	 	/s/ M. Andrew Wade	 		 		 	
	Name:	 	M. Andrew Wade	 		 		 	
	Title:	 	Chief Financial Officer	 		 		 	

 The undersigned, a Director of ATRICURE EUROPE, B.V., a company organized under the laws of The
Netherlands and a wholly owned Subsidiary of Borrower, ratifies, confirms and reaffirms, all and singular, the terms and conditions of (i) a certain Unconditional Guaranty dated as of September 26, 2012 (the “Guaranty”)
and (ii) a certain Guarantor Security Agreement, dated as of September 26, 2012 (the “Guarantor Security Agreement”), and acknowledges, confirms and agrees that the Guaranty and the Guarantor Security Agreement shall
remain in full force and effect and shall in no way be limited by the execution of this Loan Modification Agreement, or any other documents, instruments and/or agreements executed and/or delivered in connection herewith. 

 

			
	ATRICURE EUROPE, B.V.
		
	By:	 	/s/ M. Andrew Wade
	Name:	 	M. Andrew Wade
	Title:	 	Director

  
 7 

 Exhibit A to Sixth Loan Modification Agreement 

EXHIBIT B 
 COMPLIANCE CERTIFICATE 
  

			
	TO: SILICON VALLEY BANK	  	Date:                    

 FROM: ATRICURE, INC. and ATRICURE, LLC 
 The undersigned authorized officer of Atricure, Inc. (“Borrower”) certifies that under the terms and conditions of the Loan and Security Agreement between Borrower and Bank (as amended,
the “Agreement”): 
 (1) Borrower is in complete compliance for the period ending
                     with all required covenants except as noted below; (2) there are no Events of Default; (3) all representations and
warranties in the Agreement are true and correct in all material respects on this date except as noted below; provided, however, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified
or modified by materiality in the text thereof; and provided, further that those representations and warranties expressly referring to a specific date shall be true, accurate and complete in all material respects as of such date; (4) Borrower,
and each of its Subsidiaries, has timely filed all required tax returns and reports, and Borrower has timely paid all foreign, federal, state and local taxes, assessments, deposits and contributions owed by Borrower except as otherwise permitted
pursuant to the terms of Section 5.9 of the Agreement; and (5) no Liens have been levied or claims made against Borrower or any of its Subsidiaries relating to unpaid employee payroll or benefits of which Borrower has not previously
provided written notification to Bank. 
 Attached are the required documents supporting the certification. The undersigned certifies that these
are prepared in accordance with GAAP consistently applied from one period to the next except as explained in an accompanying letter or footnotes. The undersigned acknowledges that no borrowings may be requested at any time or date of determination
that Borrower is not in compliance with any of the terms of the Agreement, and that compliance is determined not just at the date this certificate is delivered. Capitalized terms used but not otherwise defined herein shall have the meanings given
them in the Agreement. 
 Please indicate compliance status by circling Yes/No under “Complies” column. 

 

					
	 Reporting Covenant
	  	 Required
	  	Complies
	Transaction Reports	  	Non-Streamline: Weekly; Streamline: monthly within 15 days	  	Yes     No
	Monthly payable & receivable items, check registers, general ledger, & reconciliations	  	Monthly within 15 days	  	Yes     No
	Monthly financial statements with Compliance Certificate	  	Monthly within 30 days	  	Yes     No
	Annual financial statement (CPA Audited)	  	FYE within 120 days	  	Yes     No
	Annual budgets and projections	  	30 days after FYE	  	Yes     No

  

													
	 Financial Covenants
	  	Required	 	 	Actual	 	  	Complies	 
	 Maintain on a Monthly Basis:
	  				 				  			
	 Minimum Liquidity Ratio (when required)
	  	 	2.00:1.00	  	 	 	        :1.00	  	  	 	Yes     No	  
	 Maximum Capital Expenditures
	  	 	*	  	 	$	                	  	  	 	Yes     No	  
	 Minimum Fixed Charge Coverage Ratio (when required)
	  	 	1.50:1.00	  	 	 	        :1.00	  	  	 	Yes     No	  
	 Minimum EBITDA (no worse than) (when required)
	  	($	4,000,000	) 	 	$	                	  	  	 	Yes     No	  

  

	*	See Loan Agreement 

  
 8 

					
	 Performance Pricing/Streamline Period

	 Streamline Requirement Met?
	  	See Loan Agreement	  	Yes     No

             Yes, interest rate on Advances equal to the Prime
Rate 
             No, interest rate on Advances equal to the Prime Rate plus one
and one-quarter percent (1.25%) 
 Borrower is party to, or bound by, the following material Restricted Licenses that were not
previously noted in the Perfection Certificate or a prior Compliance Certificate: 

                         
                                         
                                         
                                         
    . 
 Borrower intends to register the following copyrights or mask works with the United States Copyright Office that
were not previously noted in a prior Compliance Certificate: 

                         
                                         
                                         
                                         
    . 
 Borrower has (i) obtained the following Patents, registered Trademarks, registered Copyrights, registered
mask work, or any pending application for any of the foregoing, whether as owner, licensee or otherwise, and (ii) applied for the following Patents and the registration of the following Trademarks; in each case, that were not previously noted
in the Perfection Certificate or a prior Compliance Certificate (to be reported on as part of the Compliance Certificate due following the last month of each fiscal quarter): 
                                  
                                         
                                         
                                     . 

The following financial covenant analyses and information set forth in Schedule 1 attached hereto are true and accurate as of the date of this
Certificate. 
 The following are the exceptions with respect to the certification above: (If no exceptions exist, state
“No exceptions to note.”) 
  
  

 
  
  

 
  

											
	 ATRICURE, INC.

ATRICURE, LLC
	 		  	BANK USE ONLY	  	
		 		 		  	Received by:                         
                	  	
		 		 		  	AUTHORIZED SIGNER	  	
	By:	 	  
	 		  	Date:                           
                          	  	
	Name:	 	  
	 		  		  		  	
	Title:	 	  
	 		  	Verified:                          
                     	  	
		 		 		  	AUTHORIZED SIGNER	  	
		 		 		  	Date:                           
                          	  	
						
		 		 		  	Compliance Status:	  	        Yes         No	  	

  
 9 

 Schedule 1 to Compliance Certificate 

Financial Covenants of Borrower 
 In the event of a conflict between this Schedule and the Loan Agreement, the terms of the Loan Agreement shall govern. 
 Dated:                      
 I. Minimum Liquidity Ratio (Section 6.9(a)) 
 Required:
        Maintain a minimum Liquidity Ratio of at least 2.00 to 1.00 at all times, it being understood that Quarter-end Advances shall be excluded from the foregoing calculation; provided,
however, that the foregoing Liquidity Ratio covenant will no longer be tested (other than to determine the interest rate applicable to the Revolving Line as described in Section 2.3(a)), for any period commencing on the date that
Borrower provides Bank evidence satisfactory to Bank, in its reasonable discretion, that Borrower has achieved a Fixed Charge Coverage Ratio, measured on a trailing twelve month basis, as of the last day of each of the immediately preceding four
consecutive fiscal quarters of greater than 1.50:1.00 (the “FCCR Triggering Event”). 
 Actual: 

 

					
	A.	  	Borrower’s unrestricted cash (and Cash Equivalents) held with Bank and its Affiliates	  	$                
			
	B.	  	Borrower’s Eligible Accounts and Eligible EXIM Accounts	  	$                
			
	C.	  	Line A plus line B	  	$                
			
	D.	  	All outstanding liabilities and obligations of Borrower owed to Bank, including, without limitation or duplication, the face amount of any outstanding Letters of Credit (including
drawn but unreimbursed Letters of Credit but excluding the undrawn portion of the Revolving Line) (for purposes of clarity, the parties acknowledge that Borrower’s cash or Cash Equivalents shall not be considered to be restricted by reason of
the fact that they are subject to Bank’s Lien)	  	$                
			
	E.	  	Liquidity Ratio (line C divided by line D)	  	            :1.00

 Is line E greater than or equal to 2.00:1.00? 
              No, not in compliance
                                         
                                         
   Yes, in compliance 

  
 10 

 II. Maximum Capital Expenditures (Section 6.9(b)) 

Required:         Borrower shall not contract for, purchase or make any expenditure or commitments for Capital
Expenditures in an aggregate amount in excess of Four Million Dollars ($4,000,000) for Borrower’s fiscal year ending December 31, 2012, and an amount for each of Borrower’s fiscal years ending thereafter as Borrower and Bank shall
agree; provided that if Borrower and Bank fail to agree on the amount with respect to any such year, such amount shall be deemed to be Four Million Dollars ($4,000,000) for such year; provided, further, that for each fiscal
year, any Capital Expenditure amount not used by the last day of the respective fiscal year shall be added to the permitted Capital Expenditure amount for the next succeeding fiscal year Actual: 

 

					
	A.	  	Capital expenditure limit provided for in Section 6.9(b) (including any prior-year rollover amount)	  	$                
			
	B.	  	Capital expenditures for fiscal year	  	$                
			
	C.	  	Line A minus line B	  	$                

 Is line C greater than or equal to zero? 
              No, not in compliance
                                         
                                         
       Yes, in compliance 

  
 11 

 III. Minimum Fixed Charge Coverage Ratio (Section 6.9(c)) 

Required:         Achieve, measured on a trailing twelve month basis, as of the last day of each monthly period, a
Fixed Charge Coverage Ratio of not less than 1.50:1.00; provided, however, that until the occurrence of the FCCR Triggering Event described in Section 6.9(a) above, the Fixed Charge Coverage Ratio shall be measured solely
to determine whether the FCCR Triggering Event has occurred and shall not be deemed a covenant; provided further, that upon the occurrence of the FCCR Triggering Event, the Liquidity Ratio covenant contained in Section 6.9(a)
shall no longer be tested (other than to determine the interest rate applicable to the Revolving Line as described in Section 2.3(a)), and achievement of the Fixed Charge Coverage Ratio of not less than 1.50:1.00 (tested monthly, on a trailing
twelve month basis as of the last day of each monthly period), shall thereafter be required. 
 Actual: 

 

					
	A.	  	EBITDA (as defined in the Loan Agreement)	  	$            
			
	B.	  	Cash income taxes paid	  	$            
			
	C.	  	Unfinanced Capital Expenditures	  	$            
			
	D.	  	Line A minus line B minus line C	  	$            
			
	E.	  	Current portion of long term debt, other than DOJ Obligations to the extent included in the calculation of the current portion of long term debt	  	$            
			
	F.	  	 Interest Expense, other than Interest Expense on the DOJ Obligations, to the extent included

in the calculation of Interest Expense
	  	$            
			
	G	  	Line E plus line F	  	$            
			
	H.	  	Fixed Charge Coverage Ratio (line D divided by line G)	  	            :1.00

 Is line H greater than or equal to 1.50:1.00? 
              No, not in compliance
                                         
                                         
           Yes, in compliance 

  
 12 

 IV. Minimum EBITDA (Section 6.9(d)) 
 Required:         For any monthly period commencing March 1, 2013 through and including December 31, 2013 in which Borrower fails to maintain unrestricted
cash and Cash Equivalents at Bank in an amount equal to or greater than Twenty Million Dollars ($20,000,000) for each day in such monthly period, Borrower shall achieve, measured as of the end of each month, for the trailing six-month period ending
as of the end of such month, EBITDA no worse than negative Four Million Dollars ($4,000,000). Financial covenant levels for the fiscal year commencing January 1, 2014 shall be mutually determined by Borrower and Bank based on the
Borrower’s annual forecast for such fiscal year. 
 Actual: 

 

					
	A.	  	EBITDA (as defined in the Loan Agreement)	  	$            

 If unrestricted cash and Cash Equivalents at Bank was less than Twenty Million Dollars ($20,000,000) on any day during
the calendar month, is line A no worse than ($4,000,000)? 

             No, not in compliance
                                         
                                         
   Yes, in compliance 

  
 13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00215-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00215-of-00352.parquet"}]]